Today: May 29, 2017, 9:31 am
  
Health

Switzerland Pharmaceuticals & Healthcare Report Q2 2017 - New Market Research Report

Recently published research from Business Monitor International, "Switzerland Pharmaceuticals & Healthcare Report Q2 2017", is now available at Fast Market Research
Switzerland Pharmaceuticals & Healthcare Report Q2 2017 - New Market Research Report
PR-Inside.com: 2017-05-19 17:06:42
Switzerland has a well-developed healthcare system and pharmaceutical industry with its citizens enjoying extensive access to high quality health services and advanced medicines. We expect the Swiss pharmaceutical market will continue to grow in the coming years, spurred on by an aging population, which favours patented drugs over low-value generics. However, as a result of growing healthcare cost, the government will likely impose further price control mechanisms, targeting innovative medicines in particular.

The Switzerland Pharmaceuticals & Healthcare Report features BMI Research's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.


BMI's Switzerland Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Switzerland pharmaceutical and healthcare industry.

Full Report Details at
- www.fastmr.com/prod/1275214_switzerland_pharmaceuticals.aspx?afi ..

Key Benefits

Benchmark BMI's pharmaceutical and healthcare market forecasts for Switzerland, to test other views - a key input for successful budgeting and strategic business planning in the Swiss pharmaceutical and healthcare market.

Target business opportunities and risks in the Swiss pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in Switzerland.

Assess the activities, strategy and market position of your competitors using our company profiles (including SWOTs, KPIs and latest activity) and competitive landscape tables.

Coverage

BMI Industry View

An at-a-glance perspective on the latest regulatory developments, key forecast indicators and major corporate developments, covering the prescription, OTC and generics markets. The pharmaceuticals and healthcare SWOT outlines strategic factors that affect the basic assumptions underpinning BMI�s forecast analysis, and taken together with BMI�s political, economic and business environment SWOTs, it gives a complete overview of market climate.

BMI Industry Forecast Scenario

Industry forecasts to end-2019 for all key indicators, supported by explicit assumptions, plus analysis of key downside risks to the main forecasts:

Healthcare: Total healthcare expenditure (USDbn), healthcare expenditure (% of GDP), healthcare expenditure per capita (USD), hospital beds, doctors, and birth & mortality rates (all per �000 population).

Pharmaceutical Market: Drug expenditure in USDbn, % of GDP and per capita (USD).

Patented Drug Market: Prescription drug sales (USDbn & % of total sales).

Generic Drug Market: Generic product sales (USDbn), generic sales (% of total sales).

OTC Drug Market: OTC sales (USDbn & % of total sales).

Macroeconomic Forecasts: Nominal and real GDP, % real GDP growth, % private consumption growth, % industrial output growth, % consumer price index, % GDP price deflator, exports, imports, trade balance, current account balance, foreign direct investment, exchange rate against USD, government expenditure and external debt.

BMI�s Pharmaceuticals and Healthcare Risk Reward Index

BMI�s Risk Reward Index provides investors (both national and multinational) looking for opportunities in the region with a clear country-comparative assessment of the market�s risks and potential rewards. Each of the country markets are scored using a sophisticated model that includes more than 40 industry, economic and demographic data points to provide indices of highest to lowest appeal to investors, with each position explained.

Market Summary

A snapshot of key market characteristics, including total size of the pharmaceuticals and healthcare segments, growth drivers, leading therapeutic areas and the competitive landscape

Industry Developments

A focus on government healthcare reforms, epidemiological trends, mergers and acquisitions, product launches, market entries, FDI activity, R&D, biotechnology, clinical trials and supply chain issues.

Regulatory Regime

Details of the industry regulatory framework and key legislation covering the licensing of new products/services, pricing and reimbursements, intellectual property, taxation and advertising, as well as analysis of the overall regulatory burden.

Competitive Landscape

The competitive landscape section provides comparative company analyses and index by USD sales and % share of total sales � for the total pharmaceutical sector, as well as the OTC, generics and distribution sub-sectors.

Company Profiles*

About Business Monitor International

Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets. BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports. Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports. View more research from Business Monitor International at www.fastmr.com/catalog/publishers.aspx?pubid=1010&afid=701

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

Press Information


Published by
Bill Thompson
18008448156
e-mail
www.fastmr.com



# 835 Words
Related Articles
More From The Author
"Vitiligo - Pipeline Review, H1 2017" now [..]
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vitiligo - Pipeline Review, H1 2017, provides [..]
New Report Available: Rheumatoid Arthritis Therapeutics in [..]
Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable autoimmune disease that primarily affects the joints. [..]
New Market Research Report: Mexico Endoscopy Fluid [..]
GlobalData's new report, "Mexico Endoscopy Fluid Management Systems Market Outlook to 2023", provides key market data [..]
Report Published: "Eosinophilic Esophagitis - Pipeline [..]
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Eosinophilic Esophagitis - Pipeline Review, [..]
New market study, "Global Smart Backpack Market [..]
Smart backpacks are a new generation of luggage that features some advanced technological enhancements such as embedded sensors, [..]
 
More From Health
HKBU Chinese Medicine Scholars Conduct Research in [..]
HONG KONG, May 18, 2017 - (ACN Newswire) - The School of Chinese Medicine (SCM) of Hong Kong Baptist University [..]
Professor Borody calls for a National Australian [..]
SYDNEY, AU., May 19, 2017 - (ACN Newswire) - Faecal Microbiota Transplantation (FMT) leader Professor Thomas Borody (MD, PhD) [..]
Singapore eDevelopment Subsidiary Initiates Research on [..]
- Nobel Prize nominee Daryl Thompson to lead research, conducted by Global BioLife Inc., supported by Charles River Laboratories - [..]
Singapore eDevelopment Bio-Med Subsidiary Initiates Research [..]
SINGAPORE, May 22, 2017 - (ACN Newswire) - Singapore eDevelopment Ltd ("SeD"; has, through its subsidiary Global BioLife [..]
Eureka Dental Group Helps Truckers In Sacramento [..]
The trucker felt extreme pain while on the road and visited a dentist in Oklahoma where he was diagnosed with [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.